Blankenship Alex K 4/A
4/A · AngioSoma, Inc. · Filed Aug 25, 2020
Insider Transaction Report
Form 4/AAmended
AngioSoma, Inc.SOAN
Blankenship Alex K
DirectorCEO, Pres., Secr., Treas.
Transactions
- Purchase
Common stock
2017-07-19$2000.00/sh+2,000,000$4,000,000,000→ 2,500,000 total - Purchase
Series E preferred stock
2016-08-11$1000.00/sh+1,000,000$1,000,000,000→ 1,000,000 total - Purchase
Common stock
2020-08-14$500.00/sh+5,000,000$2,500,000,000→ 11,000,000 total - Purchase
Common stock
2017-04-17+500,000→ 500,000 total - Purchase
Common stock
2018-12-06+3,500,000→ 6,000,000 total
Footnotes (2)
- [F1]The shares were issued pursuant to the Issuer's 2012 Stock Plan for Directors, Officers, and Consultants that has been registered with the SEC on Form S-8.
- [F2]Issued for services rendered.